Suchergebnisse - "Remission Induction"

PubPharm (354)

91

Efficacy and safety of vedolizumab in ulcerative colitis in patients from Asian countries in the GEMINI 1 study

enthalten in: Intestinal research | 2021

von Ooi, C. | Hilmi, I. | Kim, H. | +5

92

Central Nervous System Involvement in Childhood Acute Lymphoblastic Leukemia : An Analysis of Day-One Versus Day-Eight Lumbar Punctures in Remission Induction Therapy

enthalten in: Cureus | 2021

von Arshad, U. | Jabbar, N. | Mansoor, N. | +3

93

Remission after Six Months of Induction Immunosuppressive Treatment with Mycofenolate Mofetil and Prednisolone in Patients with Lupus Nephritis: A Descriptive Cross-sectional Study

in: Journal of Nepal Medical Association | 2021

von Shailendra Shrestha | Rahul Yadav

94

Steroid response rate in childhood nephrotic syndrome at a tertiary hospital in South-Eastern Nigeria

in: Nigerian Journal of Medicine | 2021

von Chikaodili Adaeze Ibeneme | Ezinwa Olekaibenma Ezuruike | Emeka Felix Onuh

95

Subclinical synovitis detected by magnetic resonance imaging and ultrasonography following clinical remission in patients with rheumatoid arthritis: A retrospective study

in: Rheumatology & Autoimmunity | 2021

von Masao Nawata | Kazuki Someya | Takafumi Aritomi | +4

96

Efficacy and safety of vedolizumab in ulcerative colitis in patients from Asian countries in the GEMINI 1 study

in: Intestinal Research | 2021

von Choon Jin Ooi | Ida Normiha Hilmi | Hyo-Jong Kim | +5

97

Rituximab in glomerular diseases: a case series and narrative review

in: Brazilian Journal of Nephrology | 2021

von Inês Duarte | João Oliveira | Cristina Outerelo | +5

98

Reduction of biologics in rheumatoid arthritis : a systematic review and meta-analysis

enthalten in: Rheumatology international | 2020

von Vasconcelos, L. | Silva, M. | Galvao, T.

99

Surgical treatment in acromegaly : experience in Córdoba

enthalten in: Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina) | 2020

von Rendón, M. | Cecenarro, L. | Andrada, M. | +17

100

Clinical trial of low-dose decitabine (DAC) administered alone or in combination with the valproic acid (VPA) and all-trans retinoic acid (ATRA) in patients > 60 years with acute myeloid leukemia who are ineligible for standard chemotherapy : Prospective randomized multicenter phase II trial of low-dose decitabine (DAC) administered alone or in combination with the histone deacetylase inhibitor valproic acid (VPA) and all-trans retinoic acid (ATRA) in patients > 60 years with acute myeloid leukemia who are ineligible for induction chemotherapy - DECIDER Trial

enthalten in: WHO International Clinical Trials Registry Platform | 2020